• Contact Us
  • Sign Up
  • TWITTER
Microbiome Times Magazine
  • Pharma & Human Health
  • Animal Health
  • Phytobiome
  • Finance
    • Finance Articles
    • Microbiome Stocks
  • Drug Database
    • About
    • Login/ Register
  • Events
  • Advertise

Engineering Phage Particles: An Interview with Xavier Duportet, CEO & Co-founder, Eligo Bioscience

July 4, 2019 Staff Editor Editor's Choice, Pharma & Human Health, Video

Sign Up to Free Newsletter

The Microbiome Drug Database

Advertisments

Editor’s Choice

  • Seres Therapeutics Announces Positive Topline Results from SER-109 Phase 3 ECOSPOR III Study in Recurrent C. difficile Infection
    August 10, 2020
  • The integral role of the microbiome in a post-pandemic world
    August 10, 2020

Latest Headlines

Micreos initiates clinical trial to evaluate world’s first endolysin-drug as a therapy for Atopic Dermatitis

  • Siolta Therapeutics Raises $30M Series B for the Prevention and Treatment of Allergic Diseases

  • DuPont Human Microbiome Venture and Procter & Gamble Enter Research Collaboration in Next Generation Probiotics

  • New live biotherapeutics will require regulatory and scientific innovation: The importance of a defined regulatory framework

  • A bifidobacterial protein that can reduce inflammation in COVID-19 found by a RUDN geneticist

  • Micreos initiates clinical trial to evaluate world’s first endolysin-drug as a therapy for Atopic Dermatitis
  • Siolta Therapeutics Raises $30M Series B for the Prevention and Treatment of Allergic Diseases
  • DuPont Human Microbiome Venture and Procter & Gamble Enter Research Collaboration in Next Generation Probiotics
  • New live biotherapeutics will require regulatory and scientific innovation: The importance of a defined regulatory framework
  • A bifidobacterial protein that can reduce inflammation in COVID-19 found by a RUDN geneticist
  • Seres Therapeutics Announces U.S. Food and Drug Administration Correspondence Following Positive SER-109 Phase 3 Study Results
4D Pharma animal microbiome cancer Cholestoral chr hansen Cosmos ID DuPont IBD Industry Academia Industry Academic Partnerships innovation Live Biotherapeutics microbiome Microbiotica Optibiotix phage probiotics Strategic Collaboration synlogic Synthetic Biologics
No comments found
Categories
  • Animal Health
  • Editor's Choice
  • Finance
  • Pharma & Human Health
  • Phytobiome & Environment
  • Sponsored Content
  • Uncategorized
  • Video
  • Webinar
sign up

Sign up to the Microbiome Times newsletterÂ